BofA/Merrill analyst Kevin Fischbeck upgraded HCA Healthcare to Neutral, also raising its price target to $137 from $130. The analyst notes that the company missed its Q2 results with EBITDA reported about $100M below consensus, but after a 15% decline in the stock price ahead of the release, he sees the valuation as "priced to perfection" and risk/reward more balanced at 7.5-times his expected 2020 EBITDA. Fischbeck adds that he expects HCA Healthcare to address the sales mix and earnings shortfall of Q2 faster than expected by the Street.

Catheter Precision (VTAK) has received its first purchase order for LockeT from an HCA Healthcare (HCA) facility.

Augmedix (AUGX) announced the general availability of Augmedix Go for emergency departments, marking the launch of the industry's first fully-automated, generative AI powered medical documentation product for EDs across the country. The launch incorporates learnings from a pilot program with HCA Healthcare (HCA), one of the nation's leading healthcare providers. As part of the pilot, ED physicians in four HCA Healthcare hospitals utilized Augmedix Go to automate medical documentation, with the product instantaneously drafting their medical notes from patient visits. "The launch of Augmedix Go in the ED represents our unwavering commitment to develop solutions for health systems that improve their workflows. Our agility and flexible architecture, exhibited by our broad product suite and open network platform, help us address the complex and varying needs of clinicians and providers," said Manny Krakaris, CEO of Augmedix. "We have built a sophisticated platform designed to enable clinicians to be present with their patients while trusting that Augmedix technology is doing administrative work unobtrusively in the background."